Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:1097-1103

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R.M.
Right arrow Articles by Schiffrin, E.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R.M.
Right arrow Articles by Schiffrin, E.L.

(Hypertension. 1996;27:1097-1103.)
© 1996 American Heart Association, Inc.


Articles

Tyrosine Kinase Signaling Pathways Modulate Angiotensin II–Induced Calcium ([Ca2+]i) Transients in Vascular Smooth Muscle Cells

R.M. Touyz; E.L. Schiffrin

From the Medical Research Council (MRC) Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal (Quebec, Canada).

Abstract Tyrosine kinases have been implicated in vascular smooth muscle cell proliferation and contraction. Underlying mechanisms may involve Ca2+-dependent pathways. This study assesses relationships between angiotensin II (Ang II)–stimulated phospholipase C–mediated Ca2+ transients and tyrosine kinase–dependent pathways in vascular smooth muscle cells. Intracellular free Ca2+ concentration ([Ca2+]i) was measured in primary cultured unpassaged vascular smooth muscle cells derived from mesenteric resistance vessels of Wistar-Kyoto rats with the use of fura 2 methodology. [Ca2+]i effects of Ang II (1 nmol/L) were determined in vascular smooth muscle cells in which tyrosine kinase pathways were stimulated by insulin (70 µU/mL; 0.5 nmol/L), insulin-like growth factor-I (1 ng/mL; 0.13 nmol/L), or platelet-derived growth factor-BB (1 ng/mL; 0.04 nmol/L) and in cells in which tyrosine kinase was inhibited by specific inhibitors (1 µmol/L tyrphostin A-23 and genistein). Ang II elicited a rapid and transient [Ca2+]i response (from 94±8 to 239±5.8 nmol/L). Activation of the receptor tyrosine kinase by insulin, platelet-derived growth factor, and insulin-like growth factor-I significantly reduced (P<.01) Ang II–induced [Ca2+]i to 161±7, 189±3.7, and 183±5 nmol/L, respectively. In the presence of tyrphostin A-23 and genistein, Ang II–stimulated [Ca2+]i remained persistently elevated and failed to return to basal levels. Tyrphostin A-1, the inactive tyrphostin analogue, had no significant effect on Ang II–induced [Ca2+]i. This study demonstrates that activation of tyrosine kinase pathways reduces Ang II–elicited [Ca2+]i responses, whereas tyrosine kinase inhibition prevents [Ca2+]i recovery after agonist stimulation. Interaction between tyrosine kinase– and phospholipase C–dependent signaling pathways modulates vascular smooth muscle cell [Ca2+]i responses to Ang II.


Key Words: angiotensin II • calcium • protein-tyrosine kinase • insulin • platelet-derived growth factor • muscle, smooth, vascular




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
I. Woclawek-Potocka, T. J. Acosta, A. Korzekwa, M. M. Bah, M. Shibaya, K. Okuda, and D. J. Skarzynski
Phytoestrogens Modulate Prostaglandin Production in Bovine Endometrium: Cell Type Specificity and Intracellular Mechanisms
Experimental Biology and Medicine, May 1, 2005; 230(5): 326 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Salomonsson and W. J. Arendshorst
Effect of tyrosine kinase blockade on norepinephrine-induced cytosolic calcium response in rat afferent arterioles
Am J Physiol Renal Physiol, May 1, 2004; 286(5): F866 - F874.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. Che and P. K. Carmines
Angiotensin II Triggers EGFR Tyrosine Kinase-Dependent Ca2+ Influx in Afferent Arterioles
Hypertension, November 1, 2002; 40(5): 700 - 706.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y.-P. Fan, R. N. Puri, and S. Rattan
Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action
Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G461 - G469.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Hardy, F. Stanke-Labesque, M. Peoc'h, A. Hakim, P. Devillier, F. Caron, S. Morel, P. Faure, S. Halimi, and G. Bessard
Cysteinyl Leukotrienes Modulate Angiotensin II Constrictor Effects on Aortas From Streptozotocin-Induced Diabetic Rats
Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1751 - 1758.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Ceolotto, R. Valente, E. Baritono, S. Reato, E. Iori, A. Monari, R. Trevisan, and A. Semplicini
Effect of Insulin and Angiotensin II on Cell Calcium in Human Skin Fibroblasts
Hypertension, June 1, 2001; 37(6): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. K. Carmines, R. W. Fallet, Q. Che, and K. Fujiwara
Tyrosine Kinase Involvement in Renal Arteriolar Constrictor Responses to Angiotensin II
Hypertension, February 1, 2001; 37(2): 569 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. E. PURDY and W. J. ARENDSHORST
Iloprost Inhibits Inositol-1,4,5-Trisphosphate-Mediated Calcium Mobilization Stimulated by Angiotensin II in Cultured Preglomerular Vascular Smooth Muscle Cells
J. Am. Soc. Nephrol., January 1, 2001; 12(1): 19 - 28.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Tolloczko, F. C. Tao, M. E. Zacour, and J. G. Martin
Tyrosine kinase-dependent calcium signaling in airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1138 - L1145.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Samain, H. Bouillier, J. Marty, M. Safar, and G. Dagher
The Effect of Propofol on Angiotensin II-Induced Ca2+ Mobilization in Aortic Smooth Muscle Cells from Normotensive and Hypertensive Rats
Anesth. Analg., March 1, 2000; 90(3): 546 - 552.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. Samain, H. Bouillier, S. Miserey, C. Perret, J.-F. Renaud, M. Safar, and G. Dagher
Extracellular Signal-Regulated Kinase Pathway Is Involved in Basic Fibroblast Growth Factor Effect on Angiotensin II-Induced Ca2+ Transient in Vascular Smooth Muscle Cell From Wistar-Kyoto and Spontaneously Hypertensive Rats
Hypertension, January 1, 2000; 35(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. M. Ford, S. Li, and J. G. Pickering
Angiotensin II Stimulates Collagen Synthesis in Human Vascular Smooth Muscle Cells : Involvement of the AT1 Receptor, Transforming Growth Factor-{beta}, and Tyrosine Phosphorylation
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1843 - 1851.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Touyz, M. El Mabrouk, G. He, X-H. Wu, and E. L. Schiffrin
Mitogen-Activated Protein/Extracellular Signal–Regulated Kinase Inhibition Attenuates Angiotensin II–Mediated Signaling and Contraction in Spontaneously Hypertensive Rat Vascular Smooth Muscle Cells
Circ. Res., March 19, 1999; 84(5): 505 - 515.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. M. Touyz, G. He, L.-Y. Deng, and E. L. Schiffrin
Role of Extracellular Signal-Regulated Kinases in Angiotensin II–Stimulated Contraction of Smooth Muscle Cells From Human Resistance Arteries
Circulation, January 26, 1999; 99(3): 392 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. W. Watts, J. A. Florian, and K. M. Monroe
Dissociation of Angiotensin II-Stimulated Activation of Mitogen-Activated Protein Kinase Kinase from Vascular Contraction
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1431 - 1438.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. M. Touyz and E. L. Schiffrin
Growth Factors Mediate Intracellular Signaling in Vascular Smooth Muscle Cells Through Protein Kinase C–Linked Pathways
Hypertension, December 1, 1997; 30(6): 1440 - 1447.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. M. Touyz and E. L. Schiffrin
Angiotensin II Regulates Vascular Smooth Muscle Cell pH, Contraction, and Growth Via Tyrosine Kinase–Dependent Signaling Pathways
Hypertension, August 1, 1997; 30(2): 222 - 229.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato
Calcium Movements, Distribution, and Functions in Smooth Muscle
Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Tolloczko, P. Turkewitsch, S. Choudry, S. Bisotto, E. D. Fixman, and J. G. Martin
Src modulates serotonin-induced calcium signaling by regulating phosphatidylinositol 4,5-bisphosphate
Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1305 - L1313.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Wakisaka, T. Kitazono, M. Kato, U. Nakamura, M. Yoshioka, Y. Uchizono, and M. Yoshinari
Sodium-Coupled Glucose Transporter as a Functional Glucose Sensor of Retinal Microvascular Circulation
Circ. Res., June 8, 2001; 88(11): 1183 - 1188.
[Abstract] [Full Text] [PDF]